Evaluation of Lactobacillus Reuteri DSM 17938 + Vitamin D3 in the Prevention of RRI in Paediatric Patients

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2020
The aim of this protocol is to evaluate, in a multicenter, randomized, double blind vs placebo clinical trial the effects of a marketed food supplement containing Lactobacillus reuteri DSM 17938 and vitamin D3 (Reuterin® D3) in the prevention of recurrent respiratory infections in pediatric patients suffered from Recurrent Respiratory Infection (RRI) in previous years.
Epistemonikos ID: a55beb1046cd353725b1b5f72168401b72f0b969
First added on: Jan 28, 2022